Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
adenoviral vector encoding rat her-2/neu (1 trial)
adher-2/neu transduced dendritic cells (1 trial)
autologous cd34+ cells (1 trial)
Breast Neoplasms (Phase 1)
Trials (3 total)
Trial APIs (3 total)